193 related articles for article (PubMed ID: 10477441)
61. Inflammation in induced sputum after aluminium oxide exposure: an experimental chamber study.
Sikkeland L; Alexis NE; Fry RC; Martin E; Danielsen TE; Søstrand P; Kongerud J
Occup Environ Med; 2016 Mar; 73(3):199-205. PubMed ID: 26786756
[TBL] [Abstract][Full Text] [Related]
62. Budesonide reduces neutrophilic but not functional airway response to ozone in mild asthmatics.
Vagaggini B; Taccola M; Conti I; Carnevali S; Cianchetti S; Bartoli ML; Bacci E; Dente FL; Di Franco A; Giannini D; Paggiaro PL
Am J Respir Crit Care Med; 2001 Dec; 164(12):2172-6. PubMed ID: 11751182
[TBL] [Abstract][Full Text] [Related]
63. Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects.
Bascom R; Naclerio RM; Fitzgerald TK; Kagey-Sobotka A; Proud D
Am Rev Respir Dis; 1990 Sep; 142(3):594-601. PubMed ID: 2202248
[TBL] [Abstract][Full Text] [Related]
64. Prednisone blunts airway neutrophilic inflammatory response due to ozone exposure in asthmatic subjects.
Vagaggini B; Cianchetti S; Bartoli M; Ricci M; Bacci E; Dente FL; Di Franco A; Paggiaro P
Respiration; 2007; 74(1):61-8. PubMed ID: 17028419
[TBL] [Abstract][Full Text] [Related]
65. Prolonged ozone exposure in an allergic airway disease model: adaptation of airway responsiveness and airway remodeling.
Jang AS; Choi IS; Lee JH; Park CS; Park CS
Respir Res; 2006 Feb; 7(1):24. PubMed ID: 16472404
[TBL] [Abstract][Full Text] [Related]
66. Inflammatory cell availability affects ozone-induced lung damage.
Bassett D; Elbon-Copp C; Otterbein S; Barraclough-Mitchell H; Delorme M; Yang H
J Toxicol Environ Health A; 2001 Dec; 64(7):547-65. PubMed ID: 11760153
[TBL] [Abstract][Full Text] [Related]
67. Respiratory responses to repeated prolonged exposure to 0.12 ppm ozone.
Folinsbee LJ; Horstman DH; Kehrl HR; Harder S; Abdul-Salaam S; Ives PJ
Am J Respir Crit Care Med; 1994 Jan; 149(1):98-105. PubMed ID: 8111607
[TBL] [Abstract][Full Text] [Related]
68. Consequences of prolonged inhalation of ozone on F344/N rats: collaborative studies. Part XII: Atrophy of bone in nasal turbinates.
Harkema JR; Catalano PJ; Hotchkiss JA
Res Rep Health Eff Inst; 1997 Apr; (65 ( Pt 12)):1-19; discussion 21-6. PubMed ID: 9140147
[TBL] [Abstract][Full Text] [Related]
69. Repeated episodes of ozone inhalation amplifies the effects of allergen sensitization and inhalation on airway immune and structural development in Rhesus monkeys.
Schelegle ES; Miller LA; Gershwin LJ; Fanucchi MV; Van Winkle LS; Gerriets JE; Walby WF; Mitchell V; Tarkington BK; Wong VJ; Baker GL; Pantle LM; Joad JP; Pinkerton KE; Wu R; Evans MJ; Hyde DM; Plopper CG
Toxicol Appl Pharmacol; 2003 Aug; 191(1):74-85. PubMed ID: 12915105
[TBL] [Abstract][Full Text] [Related]
70. Effects of pre-existing rhinitis on ozone-induced mucous cell metaplasia in rat nasal epithelium.
Cho HY; Hotchkiss JA; Bennett CB; Harkema JR
Toxicol Appl Pharmacol; 1999 Jul; 158(2):92-102. PubMed ID: 10406924
[TBL] [Abstract][Full Text] [Related]
71. Effect of exposure to swine dust on levels of IL-8 in airway lavage fluid.
Larsson BM; Palmberg L; Malmberg PO; Larsson K
Thorax; 1997 Jul; 52(7):638-42. PubMed ID: 9246137
[TBL] [Abstract][Full Text] [Related]
72. Comparison of chamber and face-mask 6.6-hour exposures to ozone on pulmonary function and symptoms responses.
Adams WC
Inhal Toxicol; 2002 Jul; 14(7):745-64. PubMed ID: 12122573
[TBL] [Abstract][Full Text] [Related]
73. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung.
Devlin RB; McDonnell WF; Mann R; Becker S; House DE; Schreinemachers D; Koren HS
Am J Respir Cell Mol Biol; 1991 Jan; 4(1):72-81. PubMed ID: 1846079
[TBL] [Abstract][Full Text] [Related]
74. Airway hyperresponsiveness and changes in cell counts in bronchoalveolar lavage after ozone exposure in dogs.
Fabbri LM; Aizawa H; Alpert SE; Walters EH; O'Byrne PM; Gold BD; Nadel JA; Holtzman MJ
Am Rev Respir Dis; 1984 Feb; 129(2):288-91. PubMed ID: 6696327
[TBL] [Abstract][Full Text] [Related]
75. Changes in Metabolites Present in Lung-Lining Fluid Following Exposure of Humans to Ozone.
Cheng W; Duncan KE; Ghio AJ; Ward-Caviness C; Karoly ED; Diaz-Sanchez D; Conolly RB; Devlin RB
Toxicol Sci; 2018 Jun; 163(2):430-439. PubMed ID: 29471466
[TBL] [Abstract][Full Text] [Related]
76. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy.
Aris RM; Christian D; Hearne PQ; Kerr K; Finkbeiner WE; Balmes JR
Am Rev Respir Dis; 1993 Nov; 148(5):1363-72. PubMed ID: 8239177
[TBL] [Abstract][Full Text] [Related]
77. Ozone effects on the immediate-phase response to allergen in the nasal airways of allergic asthmatic subjects.
Michelson PH; Dailey L; Devlin RB; Peden DB
Otolaryngol Head Neck Surg; 1999 Feb; 120(2):225-32. PubMed ID: 9949357
[TBL] [Abstract][Full Text] [Related]
78. Endotoxin potentiates ozone-induced mucous cell metaplasia in rat nasal epithelium.
Fanucchi MV; Hotchkiss JA; Harkema JR
Toxicol Appl Pharmacol; 1998 Sep; 152(1):1-9. PubMed ID: 9772194
[TBL] [Abstract][Full Text] [Related]
79. Effect of ozone exposure on maximal airway narrowing in non-asthmatic and asthmatic subjects.
Hiltermann TJ; Stolk J; Hiemstra PS; Fokkens PH; Rombout PJ; Sont JK; Sterk PJ; Dijkman JH
Clin Sci (Lond); 1995 Dec; 89(6):619-24. PubMed ID: 8549080
[TBL] [Abstract][Full Text] [Related]
80. Relation of pulmonary responses induced by 6.6-h exposures to 0.08 ppm ozone and 2-h exposures to 0.30 ppm ozone via chamber and face-mask inhalation.
Adams WC
Inhal Toxicol; 2003 Jul; 15(8):745-59. PubMed ID: 12825151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
